Trends of inpatient palliative care use among hospitalized patients with Parkinson's diseaseDaniel G. Di Luca, Corneliu Luca, Carlos Singer et al.|Parkinsonism & Related Disorders|2020Cited by 24
Amantadine Revisited: A Contender for Initial Treatment in Parkinson’s Disease?Sarah Marmol, Jason Margolesky, Carlos Singer et al.|CNS Drugs|2021Cited by 23
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the ClinicMatthew Feldman, Jason Margolesky, Sarah Marmol|Therapeutics and Clinical Risk Management|2022Cited by 19
Opicapone for the treatment of Parkinson’s disease: a reviewMatthew Feldman, Jason Margolesky|International Journal of Neuroscience|2021Cited by 13
Blepharoclonus in ParkinsonismJason Margolesky, Michael Benatar, Corneliu Luca et al.|Neurology Clinical Practice|2023Cited by 4